<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02760095</url>
  </required_header>
  <id_info>
    <org_study_id>14-2430A</org_study_id>
    <nct_id>NCT02760095</nct_id>
  </id_info>
  <brief_title>Effects of EED on Zn Absorption and Retention in Children From a Standard Dose</brief_title>
  <acronym>ZEED1</acronym>
  <official_title>Effects of Environmental Enteric Dysfunction (EED) on Zinc (Zn) Absorption and Retention in Young Children: Study 1 - Absorption of Zn and Vitamin A From a Standard Dose</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>International Centre for Diarrhoeal Disease Research, Bangladesh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective is to determine the impact of EED on zinc absorption and homeostasis,
      and its impact on the absorptive capacity of vitamin A absorption of young children (18-24
      months of age) in an austere setting with high rates of diarrhea, stunting, and
      micro-nutrient deficiencies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participating children are screened for EED using the lactulose:mannitol ratio test and
      assigned to one of two groups: +EED or -EED. All participants will be given standard,
      physiological dose of 3 mg zinc sulfate with a zinc stable isotope tracer on study day 8.

      On study day 11, 0.5 mg of 13C10-retinyl-acetate will be administered orally to all
      participants.

      Spot urine samples will be collected twice daily from study days 11-14. Complete fecal
      collections will be obtained for days 11-14. Duplicate diets of all foods consumed will be
      collected on days 11-14. On study day 14, a blood sample will be taken for analysis of
      vitamin A isotope status.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 2015</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Absorption of zinc (AZ) from standard dose</measure>
    <time_frame>1 day</time_frame>
    <description>Absorption of zinc from standard 3 mg dose will be measured using zinc isotope tracer methods</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Endogenous fecal zinc (EFZ)</measure>
    <time_frame>4 days</time_frame>
    <description>EFZ measured from zinc isotope ratios in complete fecal collections</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vitamin A absorption</measure>
    <time_frame>1 day</time_frame>
    <description>Absorption efficiency of retinol will be measured by isotope ratios in blood</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma zinc</measure>
    <time_frame>1 day</time_frame>
    <description>Plasma zinc concentration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alkaline phosphatase</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum retinol</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Methyl malonic acid</measure>
    <time_frame>1 day</time_frame>
    <description>serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vitamin B12</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum ferritin</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Soluble transferrin receptors</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-reactive Protein (CRP)</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alpha-Glycoprotein (AGP)</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tumor necrosis factor (TNF) alpha</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum endocab</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal neopterin</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myeloperoxidase</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alpha 1 antitrypsin</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Calprotectin</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Environmental Enteric Dysfunction</condition>
  <condition>Zinc Deficiency</condition>
  <condition>Vitamin A Deficiency</condition>
  <arm_group>
    <arm_group_label>Children with EED</arm_group_label>
    <description>Children are placed in this arm if they screen positive for EED using the urinary lactulose:mannitol (L:M) recovery ratio. Children will receive a one-time 3 mg standard dose of zinc sulfate with stable isotope zinc tracer and 0.5 mg standard dose of 13C10-retinyl-acetate (vitamin A isotope).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Children without EED</arm_group_label>
    <description>Children are placed in this arm if they screen negative for EED using the urinary lactulose:mannitol (L:M) recovery ratio. Children will receive a one-time 3 mg standard dose of zinc sulfate with stable isotope zinc tracer and 0.5 mg standard dose of 13C10-retinyl-acetate (vitamin A isotope).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>3 mg zinc sulfate supplement</intervention_name>
    <arm_group_label>Children with EED</arm_group_label>
    <arm_group_label>Children without EED</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.5 mg of 13C10-retinyl-acetate</intervention_name>
    <arm_group_label>Children with EED</arm_group_label>
    <arm_group_label>Children without EED</arm_group_label>
    <other_name>Vitamin A isotope</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Spot urine samples x 4 days; complete fecal collections x 4 days; blood sample
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Toddlers aged 18-24 mos living in Dhaka, Bangladesh
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Absence of apparent health problems that would impair ability to consume regular diet,
             to tolerate zinc supplements, or to comply with demands of metabolic studies

          -  Length for age Z-score (LAZ) between -1.5 to -3.0

          -  Hemoglobin (Hgb) â‰¥ 8

        Exclusion Criteria:

          -  Outside age range

          -  Hgb &lt; 8

          -  Chronic illness

          -  Recent diarrhea (within past 2 weeks, treated with supplemental zinc)

          -  Severe stunting and/or severe acute malnutrition (SAM): LAZ &lt;-3; Weight-for-age
             Z-score (WHZ) &lt;-3 or mid-upper arm circumference (MUAC) &lt; 115 or edema
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Months</minimum_age>
    <maximum_age>24 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nancy F Krebs, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Colorado Denver School of Medicine</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>icddr,b (International Centre for Diarrheal Disease Research, Bangladesh</name>
      <address>
        <city>Dhaka</city>
        <country>Bangladesh</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bangladesh</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 24, 2015</study_first_submitted>
  <study_first_submitted_qc>April 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 3, 2016</study_first_posted>
  <last_update_submitted>May 18, 2018</last_update_submitted>
  <last_update_submitted_qc>May 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>environmental enteric dysfunction</keyword>
  <keyword>environmental enteropathy</keyword>
  <keyword>zinc</keyword>
  <keyword>vitamin A</keyword>
  <keyword>Bangladesh</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin A Deficiency</mesh_term>
    <mesh_term>Night Blindness</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin A</mesh_term>
    <mesh_term>Zinc</mesh_term>
    <mesh_term>Retinol palmitate</mesh_term>
    <mesh_term>Retinol acetate</mesh_term>
    <mesh_term>Zinc Sulfate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

